Physician profile
Robert L Summitt
NPI 1376568709
$2,580.12
in general payments reported to CMS, 2019-2025
22 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.65 · 2020: $185 · 2021: $1,065 · 2022: $221 · 2023: $460 · 2024: $290 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $752.88 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $413.67 | 2019-2024 | Veozah |
| Caldera Medical, INC | $412.05 | 2021-2023 | Desara |
| Sumitomo Pharma America, INC. | $232.52 | 2023-2025 | Gemtesa |
| Abbvie INC. | $125.37 | 2020-2025 | Botox, Orilissa, Lo Loestrin Fe |
| Boston Scientific Corporation | $79.79 | 2022-2025 | Axonics |
| Urovant Sciences INC | $72.97 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $71.95 | 2025 | |
| Hologic Sales and Service, LLC | $70.25 | 2023-2025 | Myosure Tissue Removal Device, Aptima, Novasure |
| Laborie Medical Technologies Corp. | $45.60 | 2020 | |
| Channel Medsystems, INC. | $39.31 | 2024 | |
| Pfizer INC. | $37.18 | 2024 | |
| Applied Medical Resources Corporation | $32.34 | 2023 | |
| Aspira Women'S Health INC | $29.54 | 2021 | |
| Monaghan Medical Corporation | $28.61 | 2024 | Aerochamber |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $23.95 | 2025 | Slynd |
| Provepharm INC. | $22.89 | 2025 | Bludigo |
| Coopersurgical, INC. | $22.33 | 2024 | Paragard T 380a |
| Northgate Technologies, INC. | $21.10 | 2024 | Stimsite |
| Scynexis, INC. | $17.15 | 2022 | |
| Optumhealth Care Solutions, LLC | $16.64 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Amgen INC. | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Summitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.